Clinical Trial Update: Phase I Study of Neoadjuvant Chemotherapy for Patients With Borderline Resectable Pancreatic Cancer. [Phase 1]

View source ↗

Summary

Phase I study evaluating neoadjuvant chemotherapy for patients with borderline resectable pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Wakayama Medical University | Conditions: Pancreatic Cancer | Phase 1 | Status: UNKNOWN